Supernus

Supernus SUPN Stock

$28.80   -0.826452%
Add to favorites
Market Cap
$5.98B
LOW - HIGH [24H]
$28.72 - $29.75
VOLUME [24H]
$636.64K
P/E Ratio
0
Earnings per share
-$0.76
ISIN
US8684591089
Price   Prediction

Supernus Price Chart

Sorry, that's all we've gotfor now...

Supernus (SUPN) stock price today is 28.8 USD on Tech Market Middle (-0.83% on the day). Updated .

Supernus SUPN Financial and Trading Overview

Supernus stock price 28.8 USD
Previous Close 28.83 USD
Open 28.72 USD
Bid 29.22 USD x 100
Ask 28.81 USD x 100
Day's Range 28.46 - 29.69 USD
52 Week Range 25.92 - 42.81 USD
Volume 2.81M USD
Avg. Volume 2.74M USD
Market Cap 6.03B USD
Beta (5Y Monthly) 1.132
PE Ratio (TTM) N/A
EPS (TTM) -0.76 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 54.14 USD

SUPN Valuation Measures

Enterprise Value 3.62B USD
Trailing P/E N/A
Forward P/E 7.253345
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.390326
Price/Book (mrq) N/A
Enterprise Value/Revenue 2.637
Enterprise Value/EBITDA 5.558

Trading Information

Supernus Stock Price History

Beta (5Y Monthly) 1.132
52-Week Change -10.92%
S&P500 52-Week Change 10.51%
52 Week High 42.81 USD
52 Week Low 25.92 USD
50-Day Moving Average 33.69 USD
200-Day Moving Average 35.37 USD

SUPN Share Statistics

Avg. Volume (3 month) 2.74M USD
Avg. Daily Volume (10-Days) 4.18M USD
Shares Outstanding 207.72M
Float 114.74M
Short Ratio 4.26
% Held by Insiders 2.06%
% Held by Institutions 61.21%
Shares Short 4.62M
Short % of Float 9.72%
Short % of Shares Outstanding 7.92%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 32.75%
Operating Margin (ttm) 46.94%
Gross Margin 85.73%
EBITDA Margin 47.45%

Management Effectiveness

Return on Assets (ttm) 29.33%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 1.37B USD
Revenue Per Share (ttm) 11.26 USD
Quarterly Revenue Growth (yoy) 13.40%
Gross Profit (ttm) 1.18B USD
EBITDA 652M USD
Net Income Avi to Common (ttm) 450M USD
Diluted EPS (ttm) -0.76
Quarterly Earnings Growth (yoy) 226.19%

Balance Sheet

Total Cash (mrq) 305M USD
Total Cash Per Share (mrq) 2.58 USD
Total Debt (mrq) 501M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.615
Book Value Per Share (mrq) -0.508

Cash Flow Statement

Operating Cash Flow (ttm) 96M USD
Levered Free Cash Flow (ttm) 227.12M USD

Profile of Supernus

Country United States
State MD
City Rockville
Address 9715 Key West Avenue
ZIP 20850
Phone 301 838 2500
Website https://www.supernus.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 827

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Supernus, Inc. was formerly known as Indivior Pharmaceuticals, Inc. and changed its name Supernus, Inc. in November 2026. Supernus, Inc. was incorporated in 2014 and is headquartered in Rockville, Maryland.

Q&A For Supernus Stock

What is a current SUPN stock price?

Supernus SUPN stock price today per share is 28.8 USD.

How to purchase Supernus stock?

You can buy SUPN shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Supernus?

The stock symbol or ticker of Supernus is SUPN.

Which industry does the Supernus company belong to?

The Supernus industry is Drug Manufacturers - Specialty & Generic.

How many shares does Supernus have in circulation?

The max supply of Supernus shares is 207.72M.

What is Supernus Price to Earnings Ratio (PE Ratio)?

Supernus PE Ratio is now.

What was Supernus earnings per share over the trailing 12 months (TTM)?

Supernus EPS is -0.76 USD over the trailing 12 months.

Which sector does the Supernus company belong to?

The Supernus sector is Healthcare.

Supernus SUPN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24356.87 USD —
+0.12
2.55B USD — 24268.03 USD — 24538.78 USD — — 2.55B USD —
us US Tech Composite Total Return XCMP US 30153.42 USD —
+0.3
— — 29990.36 USD — 30324.94 USD — — — —
us US Tech US 700 Small Cap Value I NQUS700SCV US 2649.53 USD —
+0.46
— — 2625.83 USD — 2654.08 USD — — — —
us US Tech Global Market Composite NQGM US 1839.09 USD —
+0.18
— — 1832.56 USD — 1855.92 USD — — — —
us US Tech Biotechnology NBI US 6986.34 USD —
-0.45
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1327.34 USD —
-0.42
— — 1322.85 USD — 1342.46 USD — — — —
us US Tech Biotechnology Total Retu XNBI US 7645.1 USD —
-0.3
— — 7605.28 USD — 7732.54 USD — — — —
us US Tech US 700 Small Cap Value N NQUS700SCVN US 3048.73 USD —
+0.46
— — 3021.53 USD — 3054.02 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 2943.08 USD —
+0.53
— — 2921.79 USD — 2953.86 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.18T
Total marketcap
$69.46B
Total volume
BTC 58.15%   •   ETH 9.90%
Dominance
Select currency